Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115747838A details a green electrochemical method for C3 amination of quinoxalinones, offering cost-effective and scalable pharma intermediate manufacturing solutions.
Patent CN106866389A reveals copper-catalyzed asymmetric synthesis. Offers high enantioselectivity up to 95% ee for pharmaceutical intermediates.
Patent CN107011218A details copper catalyzed asymmetric amination enabling efficient synthesis of chiral amines with improved supply chain reliability and cost effectiveness for global buyers
Patent CN117362140B reveals high-yield photocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Advanced metal-free synthesis of 1,2-disubstituted-4-quinolones via Claisen condensation. High yield, mild conditions, cost-effective manufacturing for pharma intermediates.
Novel cobalt-catalyzed carbonylation method offers cost-effective scalable production for pharmaceutical intermediates with high purity and operational simplicity for global supply chains.
Novel iridium-catalyzed asymmetric method offers high selectivity and mild conditions for pharmaceutical intermediate manufacturing supply chain optimization and cost efficiency.
Novel silver oxide promoted method ensures high purity and scalable production for global pharmaceutical supply chains efficiently reducing operational complexity and enhancing sourcing stability significantly.
Patent CN105859620B reveals novel phenanthridine synthesis enabling cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN116813544B reveals catalyst-free heating method for quinoline. Reduces cost and improves supply chain reliability for pharmaceutical intermediates globally.
Patent CN112480015B details a novel one-pot Pd-catalyzed method using nitro compounds, offering cost-effective and scalable production of high-purity quinazolinone derivatives.
Patent CN108503574A enables efficient Pd-Cu co-catalyzed synthesis. Delivers high-purity pharmaceutical intermediates with reduced cost and scalable supply chain reliability.
Efficient base-catalyzed route for 2H-pyran-2-one derivatives using sulfur ylides. Offers cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering cost-effective pharma intermediate manufacturing.
Novel Rh-catalyzed one-pot synthesis of indolo[2,1-a]isoquinolines using sulfur ylides. Efficient route for pharmaceutical intermediates with mild conditions.
Patent CN113896648B reveals nickel-catalyzed route for alpha beta unsaturated amides. Reduces cost and toxicity significantly. Reliable supply chain partner for pharmaceutical intermediates manufacturing.
Patent CN103539730A reveals scalable routes for Dabigatran intermediates using metal reduction or amine-promoted hydrogenation, ensuring supply continuity.
Patent CN115246786B reveals Pd-catalyzed carbonylation for high-purity intermediates. Cost-effective and scalable manufacturing solutions for global pharmaceutical supply chains.
Patent CN114539198B reveals a novel Pd-catalyzed method for heterochroman amides. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed carbonylation route enables high-purity polycyclic quinolinone production with simplified processing and substantial supply chain cost optimization for global buyers.